RecruitingNCT01694953

The Natural History Study of Mitochondrial NeuroGastroIntestinal Encephalopathy (MNGIE)

The Rare Disease Clinical Research Network Natural History Study of MNGIE


Sponsor

Columbia University

Enrollment

20 participants

Start Date

Feb 1, 2013

Study Type

OBSERVATIONAL

Conditions

Summary

This is a multi-center natural history study of Mitochondrial NeurogastroIntestinal Encephalopathy (MNGIE). Patients will be followed over time to assess clinical symptoms. The investigators hope to learn more about the disease of MNGIE as well as develop useful measures of disease status for use in future clinical trials. Additional clinical centers will be listed as they become available.


Eligibility

Min Age: 5 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with mitochondrial neurogastrointestinal encephalopathy (mngie). The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Columbia University

New York, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT01694953